-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Serina Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2024.
- Serina Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.1M.
- Serina Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.23M, a 1517% increase year-over-year.
- Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $648K, a 14.7% decline from 2022.
- Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $760K, a 24.2% decline from 2021.
- Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1M, a 7.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)